DCR-MYC: Phase Ib/II started

Dicerna began an open-label, international Phase Ib/II trial to evaluate IV DCR-MYC on days

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE